Gracell Biotechnologies Inc. (GRCL) Social Stream
Gracell Biotechnologies Inc (GRCL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Gracell Biotechnologies Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Over the past 30 weeks, GRCL's average upside potential has been 333.68%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
GRCL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GRCL as an investment opportunity.
- In the context of all US stocks, Gracell Biotechnologies Inc's upside potential (average analyst target price relative to current price) is higher than 594.82% of them.
- In terms of how Gracell Biotechnologies Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 66.66% of that group.
- In the context of Pharmaceutical Products stocks, Gracell Biotechnologies Inc's variance in analysts' estimates is lower than -59.88% of them.
- In terms of how Gracell Biotechnologies Inc fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 424.34% of that group.
In the Pharmaceutical Products industry, GRAY, GOVX, and GMTX are the three stocks most similar to Gracell Biotechnologies Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding GRCL using the data that counts. Try POWR Ratings for free.